#external
-
Study identifies molecular trigger of severe injury-induced inflammatory response
Vanderbilt researchers have discovered that early inappropriate activation of the enzyme plasmin caused by severe injury is a trigger of systemic inflammatory response syndrome and resulting organ failure. Read MoreJan 19, 2022
-
Ensuring the “best possible” medication history
About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices. Read MoreJan 18, 2022
-
H. pylori, lipid loss and stomach cancer
H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered. Read MoreJan 17, 2022
-
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. Read MoreJan 14, 2022
-
The role of integrins in kidney “integrity”
Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered. Read MoreJan 13, 2022
-
Salmonella overcomes host resistance
The invading pathogen Salmonella, a common cause of food poisoning, can change its metabolism to overcome host resistance to its colonization. Read MoreJan 13, 2022
-
Autoimmune drug shows promise in treating severe burns
A severe burn injury is not static. Within 72 hours, partial thickness burns can progress, or convert, to full thickness burns, greatly increasing the risk of infection, incapacitating scarring, and even death. Preventing the conversion is one of the most challenging aspects of treating burns, and a trans-institutional team of researchers from Vanderbilt University Medical... Read MoreJan 12, 2022
-
Vanderbilt-developed gunshot detection technology leads to arrest in Las Vegas shooting
Janos Salloi. PhD’08, is company’s chief technology officer Gunshot detection technology developed by Vanderbilt engineers and commercialized by a longtime research partner recently helped lead to an arrest in a fatal shooting in Las Vegas. Within seconds of the first shot in late August 2021, 16 sensors located along the Freemont Street Experience pedestrian mall... Read MoreJan 10, 2022
-
Major grant to bolster research on inflammation-related cancers
Cancer Research UK has awarded a 20-million-pound grant (about $26 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, Eunyoung Choi and Jimin Min to study inflammation-related cancers. Read MoreJan 25, 2019
-
Study to track teen development in those with, without autism
A new Vanderbilt study examining stress in teens with and without autism spectrum disorder is now enrolling participants, thanks to a $2.3 million, five-year grant from the National Institute of Mental Health. Read MoreJan 25, 2019
-
VUMC scientists ‘sprint’ to find anti-Zika antibodies
Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus. Read MoreJan 25, 2019
-
Trans-institutional team documents potential new treatment path for breast cancer
A team led by biomolecular engineer John Wilson and cancer biologist Rebecca Cook have found a way to trigger an immune response that targets breast cancer cells. Read MoreJan 16, 2019
-
Lindsley named fellow of National Academy of Inventors
Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors. Read MoreJan 4, 2019
-
Vanderbilt, Boehringer Ingelheim announce partnership to develop therapies for psychiatric disorders
Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery today announced two new global agreements to investigate, develop and commercialize novel small molecules targeting two distinct G-protein coupled receptors known to engage in the modulation of certain brain circuitries, which are altered in neuropsychiatric conditions such as schizophrenia. Read MoreJan 3, 2019
-
Study shows increasing nursing staff improves safety and quality in hospitals
A study in the January/February 2006 issue of the journal Health Affairs concludes that increasing the number of registered nurses and hours of nursing care per patient would save 6,700 lives. Read MoreJan 10, 2006
-
Researchers at Vanderbilt-Ingram Cancer Center uncover clue to explain invasive brain tumors
Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas, and their findings are published in this week's online edition of the journal Oncogene. Read MoreJan 10, 2006
-
African American comedy to be spotlighted by Vanderbilt; Tribute to Richard Pryor set for Jan. 23, panel discussion on Jan. 30
The legacy of entertainer Richard Pryor and history of African American comedy will be explored by Vanderbilt University at two January events sponsored by Vanderbilt's Bishop Joseph Johnson Black Cultural Center. Read MoreJan 10, 2006
-
Vanderbilt experts available to comment on Supreme Court nomination, process
Vanderbilt legal and political experts Suzanna Sherry and Stefanie Lindquist are available to discuss the qualities that make a good justice, how the Senate should seek to evaluate those qualities in Samuel Alito's confirmation hearing, and the politics surrounding Supreme Court appointments. Read MoreJan 10, 2006
-
Mapping Orion’s winds
For the past few months, Bob O'Dell has been mapping the winds blowing in the Orion Nebula, the closest stellar nursery similar to the one in which the sun was born. Read MoreJan 10, 2006
-
Noted civil rights, peace activist to headline Vanderbilt University’s 2006 Martin Luther King Commemorative Series Jan. 16-20
The Rev. James Lawson, civil rights and peace activist and a key figure in Vanderbilt University's history, will deliver the keynote address for the university's 2006 Martin Luther King Jr. Commemorative Series Jan. 16-20. Read MoreJan 3, 2006